> > ALS, Lunetta (Maugeri): "Italy is a leader in research on gene mutations...

ALS, Lunetta (Maugeri): "Italy is a leader in research on genetic mutations."

ALS, Lunetta (Maugeri): "Italy is a leader in research on genetic mutations."

(Adnkronos) - "Italy has always made a significant contribution to ALS research, representing a benchmark, for example, in the discovery of some genetic alterations linked to the disease. The scientific value built in our country over the years is strengthening...

(Adnkronos) – "Italy has always made a significant contribution to ALS research, serving as a benchmark, for example, in the discovery of certain genetic alterations linked to the disease. The scientific prowess built in our country over the years is now being strengthened thanks to collaboration with American researchers, interested in developing targeted therapies against specific genetic mutations.

Some of these, unfortunately, are particularly common in certain areas of our country. Teaming up means offering patients the opportunity to be identified and involved in studies early, paving the way for potential new therapies, which will obviously need to be tested to verify their safety and efficacy,” said Christian Lunetta, director of the Department of Rehabilitation Medicine at the IRCCS Maugeri in Milan, speaking at 'La promessa 2026,' the live marathon organized to support ALS research.

 

"From the very beginning, Italy has invested in the creation of multidisciplinary centers capable not only of caring for people with ALS, but also," the neurologist added, "of collecting clinical information and data useful for better describing patient characteristics. One example is the NeMO Clinical Centers, along with other multidisciplinary facilities across the country.

Thanks to the work of these centers, we have data collections that are essential for laying the foundations for future research." This "information could contribute not only to the development of new therapies, but also to better understanding the causes and mechanisms of a complex and heterogeneous disease like ALS," he concluded. 

News

webinfo@adnkronos.com (Web Info)

Continue on the app The news of your city, in real time.
Open in app App Store